HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (<it>cis</it>-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas

<p>Abstract</p> <p>Background</p> <p>Lymphomas frequently retain wild-type (wt) p53 function but overexpress HDM2, thereby compromising p53 activity. Therefore, lymphoma is a suitable model for studying the therapeutic value of disrupting the HDM2-p53 interaction by sma...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Sosin Angela M, Burger Angelika M, Siddiqi Aisha, Abrams Judith, Mohammad Ramzi M, Al-Katib Ayad M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2012-09-01
Sarja:Journal of Hematology & Oncology
Aiheet:
HDM2
p53
Apoptosis
MI-219
Nutlin-3
B-cell lymphoma
Small-molecule inhibitor
Autoubiquitination
Linkit:http://www.jhoonline.org/content/5/1/57
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia